PRESERVE TRIAL: Pancreatic beta-cell dysfunction restored by rosiglitazone and valsartan effects. A 52-week randomized controlled factorial study in subjects with IFG and/or IGT.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 06 Sep 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

05 May 2021 Results assessing alteration of expression of renin-angiotensin system (RAS) components including human adipose tissue and skeletal muscle published in the Obesity (Silver Spring, Md.)
06 Jan 2010 Status changed from planning to completed as reported by Netherlands Trials Register record.
26 Sep 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com